Keyphrases
3,4-dihydroxyphenylalanine
100%
Abnormal Involuntary Movements
14%
ASGR1
100%
Causal Factors
100%
Downstream Targets
14%
Dyskinesia
100%
Extracellular Signal-regulated Kinase
14%
Guanine nucleotide Exchange Factor
28%
High-resolution Tandem Mass Spectrometry
14%
Kinase Signaling
14%
Levodopa-induced Dyskinesia
71%
Macaque Model
14%
Mammalian Target of Rapamycin (mTOR)
28%
Mass Spectrometry Analysis
14%
Molecular Mechanism
14%
Mouse Model
14%
Parkinson's Disease
100%
Parkinson's Disease Model
14%
Patients with Parkinson's Disease
14%
Striatal
14%
Striatum
28%
Target of Rapamycin Kinase
28%
Therapeutic Effect
28%
Vulnerability
14%
Pharmacology, Toxicology and Pharmaceutical Science
DOPA
62%
Dyskinesia
100%
Guanine Nucleotide Exchange Factor
25%
Levodopa
100%
Macaca
12%
Mammalian Target of Rapamycin
25%
Mitogen Activated Protein Kinase
12%
Mouse
25%
Parkinson's Disease
100%
Therapeutic Effect
25%
Neuroscience
DOPA
62%
Dyskinesia
100%
Extracellular Signal-Regulated Kinases
12%
Guanine Nucleotide Exchange Factor
25%
L-DOPA
100%
Mammalian Target of Rapamycin
25%
Mass Spectrometry
12%
Parkinson's Disease
100%
Striatum
25%